Clinical Trial Update: STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from the University of Turin comparing two standard treatments for multiple myeloma in patients ineligible for autologous stem c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Turin, Italy | Conditions: Multiple Myeloma | Phase 4 | Status: ACTIVE_NOT_RECRUITING